{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T16:02:48Z","timestamp":1786550568530,"version":"build-2736575974"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T00:00:00Z","timestamp":1747699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurocrit Care"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s12028-025-02277-2","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T15:42:49Z","timestamp":1747755769000},"page":"18-26","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Systolic Blood Pressure Reduction with Stability as a New Therapeutic Goal in Patients with Intracerebral Hemorrhage: Results of the Pooled Analysis of ATACH 2 and INTERACT 2 Trials"],"prefix":"10.1007","volume":"44","author":[{"given":"Adnan I.","family":"Qureshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Baskett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee H.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pashmeen","family":"Lakhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8579-5593","authenticated-orcid":false,"given":"Ibrahim A.","family":"Bhatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hijrah","family":"El Sabae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fawaz","family":"Al-Mufti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joao A.","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Seifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro A.","family":"Rabinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose I.","family":"Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Ren","family":"Shyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig S.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"key":"2277_CR1","doi-asserted-by":"publisher","first-page":"e282","DOI":"10.1161\/STR.0000000000000407","volume":"53","author":"SM Greenberg","year":"2022","unstructured":"Greenberg SM, Ziai WC, Cordonnier C, et al. Guideline for the management of patients with spontaneous intracerebral hemorrhage: a guideline from the american heart association\/American stroke association. Stroke. 2022;53:e282\u2013361.","journal-title":"Stroke"},{"key":"2277_CR2","doi-asserted-by":"publisher","DOI":"10.1177\/23969873211026998","author":"EC Sandset","year":"2021","unstructured":"Sandset EC, Anderson CS, Bath PM, et al. European stroke organisation (ESO) guidelines on blood pressure management in acute ischaemic stroke and intracerebral haemorrhage. Eur Stroke J. 2021. https:\/\/doi.org\/10.1177\/23969873211026998.","journal-title":"Eur Stroke J"},{"key":"2277_CR3","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1056\/NEJMoa1214609","volume":"368","author":"CS Anderson","year":"2013","unstructured":"Anderson CS, Heeley E, Huang Y, et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med. 2013;368:2355\u201365.","journal-title":"N Engl J Med"},{"key":"2277_CR4","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1161\/STROKEAHA.118.022133","volume":"49","author":"A de Havenon","year":"2018","unstructured":"de Havenon A, Majersik JJ, Stoddard G, et al. Increased blood pressure variability contributes to worse outcome after intracerebral hemorrhage. Stroke. 2018;49:1981\u20134.","journal-title":"Stroke"},{"key":"2277_CR5","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/S1474-4422(14)70018-3","volume":"13","author":"L Manning","year":"2014","unstructured":"Manning L, Hirakawa Y, Arima H, et al. Blood pressure variability and outcome after acute intracerebral haemorrhage: a post-hoc analysis of INTERACT2, a randomised controlled trial. Lancet Neurol. 2014;13:364\u201373.","journal-title":"Lancet Neurol"},{"key":"2277_CR6","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1056\/NEJMoa1603460","volume":"375","author":"AI Qureshi","year":"2016","unstructured":"Qureshi AI, Palesch YY, Barsan WG, et al. Intensive blood-pressure lowering in patients with acute cerebral hemorrhage. N Engl J Med. 2016;375:1033\u201343.","journal-title":"N Engl J Med"},{"key":"2277_CR7","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S1474-4422(19)30196-6","volume":"18","author":"TJ Moullaali","year":"2019","unstructured":"Moullaali TJ, Wang X, Martin RH, et al. Blood pressure control and clinical outcomes in acute intracerebral haemorrhage: a preplanned pooled analysis of individual participant data. Lancet Neurol. 2019;18:857\u201364.","journal-title":"Lancet Neurol"},{"key":"2277_CR8","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1161\/STROKEAHA.111.000758","volume":"44","author":"AI Qureshi","year":"2013","unstructured":"Qureshi AI. The importance of acute hypertensive response in ICH. Stroke. 2013;44:S67\u20139.","journal-title":"Stroke"},{"key":"2277_CR9","first-page":"1783","volume":"27","author":"S Kazui","year":"1996","unstructured":"Kazui S, Naritomi H, Yamamoto H, Sawada T, Yamaguchi T. Enlargement of spontaneous intracerebral hemorrhage. Incidence Time Course Stroke. 1996;27:1783\u20137.","journal-title":"Incidence Time Course Stroke"},{"key":"2277_CR10","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1161\/01.STR.0000128795.38283.4b","volume":"35","author":"K Ohwaki","year":"2004","unstructured":"Ohwaki K, Yano E, Nagashima H, Hirata M, Nakagomi T, Tamura A. Blood pressure management in acute intracerebral hemorrhage: relationship between elevated blood pressure and hematoma enlargement. Stroke. 2004;35:1364\u20137.","journal-title":"Stroke"},{"key":"2277_CR11","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1001\/archneurol.2010.61","volume":"67","author":"AI Qureshi","year":"2010","unstructured":"Qureshi AI, Palesch YY, Martin R, et al. Effect of systolic blood pressure reduction on hematoma expansion, perihematomal edema, and 3-month outcome among patients with intracerebral hemorrhage: results from the antihypertensive treatment of acute cerebral hemorrhage study. Arch Neurol. 2010;67:570\u20136.","journal-title":"Arch Neurol"},{"key":"2277_CR12","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(08)70069-3","volume":"7","author":"CS Anderson","year":"2008","unstructured":"Anderson CS, Huang Y, Wang JG, et al. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol. 2008;7:391\u20139.","journal-title":"Lancet Neurol"},{"key":"2277_CR13","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s40258-017-0310-5","volume":"15","author":"NJ Devlin","year":"2017","unstructured":"Devlin NJ, Brooks R. EQ-5D and the EuroQol Group: Past, Present and Future. Appl Health Econ Health Policy. 2017;15:127\u201337.","journal-title":"Appl Health Econ Health Policy"},{"key":"2277_CR14","unstructured":"Hennekens CH, Buring JE, Mayrent SL. Epidemiology in medicine. In: 1st edition ed. Boston, Massachusetts: Little, Brown; 1987."},{"key":"2277_CR15","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1161\/STROKEAHA.117.019845","volume":"49","author":"AI Qureshi","year":"2018","unstructured":"Qureshi AI, Palesch YY, Foster LD, et al. Blood pressure-attained analysis of ATACH 2 trial. Stroke. 2018;49:1412\u20138.","journal-title":"Stroke"},{"key":"2277_CR16","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209244","volume":"102","author":"D Rodriguez-Luna","year":"2024","unstructured":"Rodriguez-Luna D, Pancorbo O, Llull L, et al. Effects of achieving rapid, intensive, and sustained blood pressure reduction in intracerebral hemorrhage expansion and functional outcome. Neurology. 2024;102: e209244.","journal-title":"Neurology"},{"key":"2277_CR17","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1001\/jamaneurol.2019.1141","volume":"76","author":"AC Leasure","year":"2019","unstructured":"Leasure AC, Qureshi AI, Murthy SB, et al. Association of intensive blood pressure reduction with risk of hematoma expansion in patients with deep intracerebral hemorrhage. JAMA Neurol. 2019;76:949\u201355.","journal-title":"JAMA Neurol"},{"key":"2277_CR18","first-page":"A14","volume":"4","author":"B Levine","year":"2007","unstructured":"Levine B. What does the population attributable fraction mean? Prev Chronic Dis. 2007;4:A14.","journal-title":"Prev Chronic Dis"},{"key":"2277_CR19","doi-asserted-by":"publisher","first-page":"829","DOI":"10.2307\/2529268","volume":"32","author":"SD Walter","year":"1976","unstructured":"Walter SD. The estimation and interpretation of attributable risk in health research. Biometrics. 1976;32:829\u201349.","journal-title":"Biometrics"},{"key":"2277_CR20","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.hest.2024.06.001","volume":"5","author":"A Mengel","year":"2024","unstructured":"Mengel A, Siokas V, Buesink R, et al. Continuous arterial blood pressure indices and early hematoma expansion in patients with spontaneous intracerebral hemorrhage. Brain Hemorrhages. 2024;5:213\u201322.","journal-title":"Brain Hemorrhages"},{"key":"2277_CR21","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s12028-020-01016-z","volume":"33","author":"AA Divani","year":"2020","unstructured":"Divani AA, Liu X, Petersen A, et al. The magnitude of blood pressure reduction predicts poor in-hospital outcome in acute intracerebral hemorrhage. Neurocrit Care. 2020;33:389\u201398.","journal-title":"Neurocrit Care"},{"key":"2277_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1113","volume":"8","author":"LR \u00d8ie","year":"2018","unstructured":"\u00d8ie LR, Madsbu MA, Solheim O, et al. Functional outcome and survival following spontaneous intracerebral hemorrhage: a retrospective population-based study. Brain Behav. 2018;8: e01113.","journal-title":"Brain Behav"},{"key":"2277_CR23","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1212\/01.wnl.0000208400.08722.7c","volume":"66","author":"ML Flaherty","year":"2006","unstructured":"Flaherty ML, Haverbusch M, Sekar P, et al. Long-term mortality after intracerebral hemorrhage. Neurology. 2006;66:1182\u20136.","journal-title":"Neurology"},{"key":"2277_CR24","doi-asserted-by":"publisher","first-page":"221103","DOI":"10.1001\/jamanetworkopen.2022.1103","volume":"5","author":"D Woo","year":"2022","unstructured":"Woo D, Comeau ME, Venema SU, et al. Risk factors associated with mortality and neurologic disability after intracerebral hemorrhage in a racially and ethnically diverse cohort. JAMA Netw Op. 2022;5:221103.","journal-title":"JAMA Netw Op"},{"key":"2277_CR25","doi-asserted-by":"publisher","first-page":"e001113","DOI":"10.1136\/bmjoq-2020-001113","volume":"10","author":"JS Minhas","year":"2021","unstructured":"Minhas JS, Sammut-Powell C, Birleson E, Patel HC, Parry-Jones AR. Are do-not-resuscitate orders associated with limitations of care beyond their intended purpose in patients with acute intracerebral haemorrhage? Analysis of the ABC-ICH study. BMJ Open Qual. 2021;10:e001113.","journal-title":"BMJ Open Qual."},{"key":"2277_CR26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/ijs.12161","volume":"9","author":"K Silvennoinen","year":"2014","unstructured":"Silvennoinen K, Meretoja A, Strbian D, Putaala J, Kaste M, Tatlisumak T. Do-not-resuscitate (DNR) orders in patients with intracerebral hemorrhage. Int J Stroke. 2014;9:53\u20138.","journal-title":"Int J Stroke"},{"key":"2277_CR27","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s42466-023-00256-6","volume":"5","author":"D Haupenthal","year":"2023","unstructured":"Haupenthal D, Schwab S, Kuramatsu JB. Hematoma expansion in intracerebral hemorrhage - the right target? Neurol Res Pract. 2023;5:36.","journal-title":"Neurol Res Pract"},{"key":"2277_CR28","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/ana.25793","volume":"88","author":"Q Li","year":"2020","unstructured":"Li Q, Warren AD, Qureshi AI, et al. Ultra-early blood pressure reduction attenuates hematoma growth and improves outcome in intracerebral hemorrhage. Ann Neurol. 2020;88:388\u201395.","journal-title":"Ann Neurol"},{"key":"2277_CR29","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1089\/neu.2010.1680","volume":"28","author":"YH Sang","year":"2011","unstructured":"Sang YH, Su HX, Wu WT, So KF, Cheung RT. Elevated blood pressure aggravates intracerebral hemorrhage-induced brain injury. J Neurotrauma. 2011;28:2523\u201334.","journal-title":"J Neurotrauma"},{"key":"2277_CR30","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1177\/0271678X17725431","volume":"38","author":"AI Qureshi","year":"2018","unstructured":"Qureshi AI, Qureshi MH. Acute hypertensive response in patients with intracerebral hemorrhage pathophysiology and treatment. J Cereb Blood Flow Metab. 2018;38:1551\u201363.","journal-title":"J Cereb Blood Flow Metab"},{"key":"2277_CR31","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1161\/STROKEAHA.114.004993","volume":"45","author":"G Xi","year":"2014","unstructured":"Xi G, Hua Y, Keep RF. Blood pressure lowering and acute perihematomal brain edema after intracerebral hemorrhage. Stroke. 2014;45:1241\u20132.","journal-title":"Stroke"},{"key":"2277_CR32","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1161\/STROKEAHA.119.024838","volume":"50","author":"AC Leasure","year":"2019","unstructured":"Leasure AC, Qureshi AI, Murthy SB, et al. Intensive blood pressure reduction and Perihematomal Edema expansion in deep intracerebral hemorrhage. Stroke. 2019;50:2016\u201322.","journal-title":"Stroke"},{"key":"2277_CR33","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1161\/STROKEAHA.115.010054","volume":"46","author":"SB Murthy","year":"2015","unstructured":"Murthy SB, Moradiya Y, Dawson J, Lees KR, Hanley DF, Ziai WC. Perihematomal Edema and functional outcomes in intracerebral hemorrhage: influence of hematoma volume and location. Stroke. 2015;46:3088\u201392.","journal-title":"Stroke"},{"key":"2277_CR34","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1212\/WNL.0b013e3181c55ed3","volume":"73","author":"H Arima","year":"2009","unstructured":"Arima H, Wang JG, Huang Y, et al. Significance of perihematomal edema in acute intracerebral hemorrhage: the INTERACT trial. Neurology. 2009;73:1963\u20138.","journal-title":"Neurology"},{"key":"2277_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2024.111487","volume":"174","author":"LJ Cheng","year":"2024","unstructured":"Cheng LJ, Chen LA, Cheng JY, Herdman M, Luo N. Systematic review reveals that EQ-5D minimally important differences vary with treatment type and may decrease with increasing baseline score. J Clin Epidemiol. 2024;174: 111487.","journal-title":"J Clin Epidemiol"},{"key":"2277_CR36","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1161\/STROKEAHA.120.033872","volume":"52","author":"RA Joundi","year":"2021","unstructured":"Joundi RA, Rebchuk AD, Field TS, et al. Health-related quality of life among patients with acute ischemic stroke and large vessel occlusion in the ESCAPE trial. Stroke. 2021;52:1636\u201342.","journal-title":"Stroke"},{"key":"2277_CR37","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1161\/STROKEAHA.113.001126","volume":"44","author":"M Ali","year":"2013","unstructured":"Ali M, Fulton R, Quinn T, Brady M. How well do standard stroke outcome measures reflect quality of life? A retrospective analysis of clinical trial data. Stroke. 2013;44:3161\u20135.","journal-title":"Stroke"}],"container-title":["Neurocritical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-025-02277-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12028-025-02277-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-025-02277-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T19:15:08Z","timestamp":1768936508000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12028-025-02277-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["2277"],"URL":"https:\/\/doi.org\/10.1007\/s12028-025-02277-2","relation":{},"ISSN":["1541-6933","1556-0961"],"issn-type":[{"value":"1541-6933","type":"print"},{"value":"1556-0961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,20]]},"assertion":[{"value":"14 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Qureshi is confounder of Qureshi Medical LLC, QureVasc LLC, and DyQure LLC. Dr. Qureshi also holds a patent on intraarterial sustained release device in the middle meningeal artery.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study used publicly available trial data, and consent was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval\/Informed Consent"}}]}}